Julius Randle

#30 PF

New York Knicks

Status

GTD - Shoulder - Surgery Expected Return: 2024-10-01

Previous game (vs. MIA 1/27)

PTS

REB

AST

BLK

STL

Latest Julius Randle news

The Knicks announced that Randle underwent successful surgery on his right shoulder Tuesday and will be re-evaluated in five months, Ian Begley of SportsNet New York reports. Randle tried to avoid surgery and return for the playoffs but ultimately had to be shut down for the season in early April after dislocating his right shoulder at the end of January. He ended the 2023-24 campaign with averages of 24.0 points, 9.2 rebounds, 5.0 assists and 1.7 three-pointers in 35.4 minutes across 46 appearances. Randle is under contract for at least one more season, with a player option worth $29.46 million for 2025-26. His re-evaluation timeline cuts it close to the start of training camp next fall, but there's been no indication Randle is at risk of missing the start of the 2024-25 season.

2023-24 Season Stats

PTS

REB

AST

BLK

STL

24.0

9.2

5.0

0.3

0.5

3.5

Career Averages

PTS

REB

AST

BLK

STL

19.1

9.4

3.7

0.4

0.7

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2023-24	46	46	35.4	24.0	9.2	5.0	0.3	0.5	3.5	18	1	1.7	5.3	31.1%	6.9	12.9	53.9%	8.6	18.2	47.2%	5.1	6.6	78.1%	2.2	7.0	2.7	1.4	+219	56.9%
2022-23	77	77	35.5	25.1	10.0	4.1	0.3	0.6	2.8	40	0	2.8	8.3	34.3%	5.7	10.3	55.3%	8.5	18.6	45.9%	5.2	6.9	75.7%	1.8	8.1	3.0	1.5	+171	58.1%
2021-22	72	72	35.3	20.1	9.9	5.1	0.5	0.7	3.4	31	1	1.7	5.4	30.8%	5.4	11.9	45.8%	7.1	17.3	41.1%	4.2	5.6	75.6%	1.7	8.2	2.8	1.5	-164	50.9%
2020-21	71	71	37.6	24.1	10.2	6.0	0.3	0.9	3.4	41	6	2.3	5.5	41.1%	6.2	13.1	47.4%	8.5	18.6	45.6%	4.9	6.0	81.1%	1.2	9.0	3.2	1.8	+153	56.7%
2019-20	64	64	32.5	19.5	9.7	3.1	0.3	0.8	3.0	30	0	1.0	3.6	27.7%	6.2	12.1	51.5%	7.2	15.7	46.0%	4.0	5.5	73.3%	2.4	7.4	2.8	1.0	-244	53.8%
2018-19	73	49	30.6	21.4	8.7	3.1	0.6	0.7	2.8	31	1	0.9	2.7	34.4%	6.9	12.2	56.4%	7.8	14.9	52.4%	4.9	6.7	73.1%	2.2	6.5	3.4	1.1	-12	60.0%
2017-18	82	49	26.7	16.1	8.0	2.6	0.5	0.5	2.6	28	1	0.1	0.5	22.2%	6.0	10.5	57.5%	6.1	11.0	55.8%	3.7	5.2	71.8%	2.2	5.8	3.3	1.0	-81	60.6%
2016-17	74	73	30.1	13.2	8.6	3.6	0.5	0.7	2.3	0	0	0.2	0.9	27.0%	4.9	9.6	50.7%	5.1	10.4	48.8%	2.8	3.8	72.3%	2.0	6.6	3.4	1.5	+0	54.3%
2015-16	81	60	28.2	11.3	10.2	1.8	0.4	0.7	1.8	2	0	0.1	0.4	27.8%	4.3	9.9	43.6%	4.4	10.3	42.9%	2.4	3.3	71.5%	2.1	8.1	3.0	1.0	+0	48.2%
2014-15	1	0	14.0	2.0	0.0	0.0	0.0	0.0	1.0	0	0	0.0	0.0	0.0%	1.0	3.0	33.3%	1.0	3.0	33.3%	0.0	2.0	0.0%	0.0	0.0	1.0	0.0	+0	25.8%
Career	641	561	32.2	19.1	9.4	3.7	0.4	0.7	2.8	221	10	1.2	3.5	33.3%	5.8	11.3	51.3%	6.9	14.7	47.0%	4.1	5.4	74.8%	2.0	7.4	3.1	1.3	+42	55.7%

Career Averages

PTS

REB

AST

BLK

STL

17.1

9.4

3.7

0.2

0.5

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2022-23	10	10	33.0	16.6	8.3	3.6	0.3	0.5	3.5	4	1.7	6.6	25.8%	3.8	8.1	46.9%	5.5	14.7	37.4%	3.9	5.5	70.9%	1.7	6.6	2.4	1.0	+15	48.5%
2020-21	5	5	36.0	18.0	11.6	4.0	0.0	0.6	4.6	5	2.2	6.6	33.3%	3.4	12.2	27.9%	5.6	18.8	29.8%	4.6	5.4	85.2%	2.2	9.4	3.6	0.9	-42	42.5%
Career	15	15	34.0	17.1	9.4	3.7	0.2	0.5	3.9	9	1.9	6.6	28.3%	3.7	9.5	38.7%	5.5	16.1	34.4%	4.1	5.5	75.6%	1.9	7.5	2.8	1.0	-27	46.2%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/18	WAS	L 131-106	28	20	10	0	0	0	1	6	4	66.7%	9	4	44.4%	15	8	53.3%	2	0	0.0%	2	8	0.0	-8	1	20	63.0%
10/14	MIN	L 121-112	23	7	8	4	0	0	2	5	2	40.0%	3	0	0.0%	8	2	25.0%	4	1	25.0%	0	8	2.0	+11	2	9	35.9%
10/9	BOS	W 114-107	12	11	4	0	0	0	1	2	1	50.0%	2	2	100.0%	4	3	75.0%	4	4	100.0%	1	3	0.0	+10	0	17	95.5%
Preseason Totals			21.6	12.7	7.3	1.3	0.0	0.0	1.3	4.3	2.3	53.8%	4.7	2.0	42.9%	9.0	4.3	48.1%	3.3	1.7	50.0%	1.0	6.3	1.0	+13	1.0	16.3	60.5%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
1/27	MIA	W 125-109	32	19	9	3	0	0	4	4	3	75.0%	10	3	30.0%	14	6	42.9%	4	4	100.0%	3	6	0.8	+3	2	20	60.3%
1/25	DEN	W 122-84	30	17	7	8	0	1	2	5	1	20.0%	10	6	60.0%	15	7	46.7%	2	2	100.0%	3	4	4.0	+25	2	22	53.5%
1/23	BKN	W 108-103	36	30	9	7	0	0	4	2	2	100.0%	17	8	47.1%	19	10	52.6%	8	8	100.0%	2	7	1.8	-3	3	36	66.6%
1/20	TOR	W 126-100	32	18	16	10	0	0	7	7	3	42.9%	6	4	66.7%	13	7	53.8%	2	1	50.0%	7	9	1.4	+16	3	30	64.8%
1/18	WAS	W 113-109	38	21	8	5	0	0	5	8	3	37.5%	9	5	55.6%	17	8	47.1%	4	2	50.0%	1	7	1.0	+1	2	16	56.0%
1/17	HOU	W 109-94	34	31	8	4	1	0	4	8	4	50.0%	11	7	63.6%	19	11	57.9%	6	5	83.3%	2	6	1.0	+15	4	30	71.6%
1/15	ORL	L 98-94	38	15	6	5	0	0	0	9	2	22.2%	9	3	33.3%	18	5	27.8%	5	3	60.0%	1	5	0.0	+2	3	11	37.1%
1/13	MEM	W 106-94	35	24	11	5	1	0	6	6	1	16.7%	15	8	53.3%	21	9	42.9%	6	5	83.3%	5	6	0.8	+10	2	21	50.8%
1/11	DAL	L 128-124	37	32	6	5	0	2	4	7	2	28.6%	16	10	62.5%	23	12	52.2%	7	6	85.7%	1	5	1.3	-1	3	31	61.3%
1/9	POR	W 112-84	31	20	7	8	1	0	2	4	2	50.0%	13	5	38.5%	17	7	41.2%	4	4	100.0%	0	7	4.0	+31	1	24	53.3%
1/6	WAS	W 121-105	37	39	7	5	0	1	2	8	3	37.5%	15	10	66.7%	23	13	56.5%	13	10	76.9%	3	4	2.5	+24	2	42	67.9%
1/5	PHI	W 128-92	30	8	7	5	1	1	4	3	0	0.0%	8	1	12.5%	11	1	9.1%	6	6	100.0%	0	7	1.3	+13	3	8	29.3%
1/3	CHI	W 116-100	38	35	6	4	1	2	3	7	3	42.9%	16	10	62.5%	23	13	56.5%	7	6	85.7%	0	6	1.3	+13	3	39	67.1%
1/1	MIN	W 112-106	36	39	9	0	0	0	6	6	2	33.3%	18	12	66.7%	24	14	58.3%	13	9	69.2%	3	6	0.0	+2	5	28	65.6%
12/30	IND	L 140-126	39	28	12	4	0	0	5	5	1	20.0%	17	8	47.1%	22	9	40.9%	13	9	69.2%	6	6	0.8	-6	1	21	50.5%
12/29	ORL	L 117-108	36	38	12	6	1	0	5	4	0	0.0%	21	16	76.2%	25	16	64.0%	8	6	75.0%	3	9	1.2	+0	5	39	66.6%
12/27	OKC	L 129-120	35	25	9	2	0	0	3	4	1	25.0%	11	6	54.5%	15	7	46.7%	13	10	76.9%	1	8	0.7	-12	3	22	60.3%
12/25	MIL	W 129-122	40	24	9	2	0	1	4	5	2	40.0%	12	6	50.0%	17	8	47.1%	6	6	100.0%	1	8	0.5	+6	3	25	61.1%
12/23	MIL	L 130-111	33	26	8	1	0	1	3	2	0	0.0%	15	8	53.3%	17	8	47.1%	10	10	100.0%	1	7	0.3	-3	3	29	60.7%
12/20	BKN	W 121-102	34	26	7	4	0	0	1	4	0	0.0%	16	9	56.3%	20	9	45.0%	9	8	88.9%	2	5	4.0	+27	3	25	54.3%
12/18	LAL	W 114-109	43	27	14	3	0	0	2	4	1	25.0%	18	11	61.1%	22	12	54.5%	2	2	100.0%	1	13	1.5	+17	3	31	59.0%
12/16	LAC	L 144-122	30	22	4	3	0	0	3	3	0	0.0%	14	8	57.1%	17	8	47.1%	6	6	100.0%	2	2	1.0	-20	3	17	56.0%
12/15	PHX	W 139-122	35	23	8	6	1	0	5	3	1	33.3%	13	9	69.2%	16	10	62.5%	2	2	100.0%	1	7	1.2	+4	4	24	68.1%
12/13	UTA	L 117-113	39	32	12	6	1	1	2	6	2	33.3%	17	12	70.6%	23	14	60.9%	2	2	100.0%	3	9	3.0	+13	4	38	67.0%
12/11	TOR	W 136-130	34	34	8	5	0	0	3	3	1	33.3%	18	13	72.2%	21	14	66.7%	7	5	71.4%	3	5	1.7	-1	1	37	70.6%
12/8	BOS	L 133-123	33	20	5	3	1	1	6	4	3	75.0%	11	4	36.4%	15	7	46.7%	4	3	75.0%	1	4	0.5	-18	2	14	59.7%
12/5	MIL	L 146-122	36	41	6	5	0	0	4	2	2	100.0%	17	12	70.6%	19	14	73.7%	12	11	91.7%	3	3	1.3	-21	3	45	84.4%
12/1	TOR	W 119-106	35	20	10	9	0	0	2	4	1	25.0%	11	7	63.6%	15	8	53.3%	3	3	100.0%	2	8	4.5	+15	3	30	61.3%
11/30	DET	W 118-112	38	29	10	8	1	0	3	5	2	40.0%	16	10	62.5%	21	12	57.1%	6	3	50.0%	2	8	2.7	+11	3	33	61.3%
11/28	CHA	W 115-91	34	25	20	5	0	2	4	7	2	28.6%	8	6	75.0%	15	8	53.3%	8	7	87.5%	4	16	1.3	+27	2	43	67.5%
11/26	PHX	L 116-113	35	28	5	2	0	0	2	4	1	25.0%	17	9	52.9%	21	10	47.6%	8	7	87.5%	3	2	1.0	-9	2	23	57.1%
11/24	MIA	W 100-98	35	13	8	7	0	0	6	4	1	25.0%	8	4	50.0%	12	5	41.7%	2	2	100.0%	0	8	1.2	-8	0	16	50.5%
11/20	MIN	L 117-100	33	21	14	1	0	0	2	6	1	16.7%	10	5	50.0%	16	6	37.5%	12	8	66.7%	3	11	0.5	-13	2	24	49.3%
11/18	CHA	W 122-108	37	21	6	8	0	0	4	5	2	40.0%	12	6	50.0%	17	8	47.1%	7	3	42.9%	0	6	2.0	+9	4	19	52.3%
11/17	WAS	W 120-99	35	22	7	8	2	1	6	5	1	20.0%	13	8	61.5%	18	9	50.0%	6	3	50.0%	1	6	1.3	+15	3	22	53.3%
11/15	ATL	W 116-114	38	29	10	8	0	1	1	5	3	60.0%	19	9	47.4%	24	12	50.0%	2	2	100.0%	2	8	8.0	+12	4	31	58.3%
11/13	BOS	L 114-98	37	25	9	5	0	0	3	8	2	25.0%	11	5	45.5%	19	7	36.8%	11	9	81.8%	3	6	1.7	-10	4	25	52.4%
11/12	CHA	W 129-107	27	23	5	5	0	3	3	4	1	25.0%	12	7	58.3%	16	8	50.0%	8	6	75.0%	1	4	1.7	+8	1	27	58.9%
11/8	SAS	W 126-105	31	23	16	5	0	1	2	6	2	33.3%	13	6	46.2%	19	8	42.1%	8	5	62.5%	4	12	2.5	+31	1	30	51.1%
11/6	LAC	W 111-97	36	27	10	3	0	0	6	8	3	37.5%	13	6	46.2%	21	9	42.9%	6	6	100.0%	2	8	0.5	+2	3	21	57.1%
11/3	MIL	L 110-105	38	16	12	5	0	2	1	9	1	11.1%	11	4	36.4%	20	5	25.0%	9	5	55.6%	4	8	5.0	-5	4	13	33.4%
11/1	CLE	L 95-89	35	6	6	4	0	1	3	6	0	0.0%	9	3	33.3%	15	3	20.0%	0	0	0.0%	0	6	1.3	-4	2	0	20.0%
10/31	CLE	W 109-91	31	19	10	2	0	1	1	5	2	40.0%	9	3	33.3%	14	5	35.7%	10	7	70.0%	3	7	2.0	+18	1	24	51.6%
10/28	NOP	L 96-87	33	10	12	4	0	0	8	5	0	0.0%	10	4	40.0%	15	4	26.7%	2	2	100.0%	0	12	0.5	-11	4	5	31.5%
10/27	ATL	W 126-120	34	17	12	9	0	0	3	7	3	42.9%	3	1	33.3%	10	4	40.0%	8	6	75.0%	2	10	3.0	+7	3	28	62.9%
10/25	BOS	L 108-104	34	14	11	7	0	2	0	8	3	37.5%	14	2	14.3%	22	5	22.7%	5	1	20.0%	4	7	0.0	-13	3	10	28.9%
Regular Season Totals			35.4	24.0	9.2	5.0	0.3	0.5	3.5	5.3	1.7	31.1%	12.9	6.9	53.9%	18.2	8.6	47.2%	6.6	5.1	78.1%	2.2	7.0	1.4	+219	2.7	29.2	56.9%

Julius Randle

#30 PF

Status

Previous game (vs. MIA 1/27)

Latest Julius Randle news

Undergoes successful surgery

2023-24 Season Stats

Julius Randle Career Stats

Career Averages

Career Averages

Julius Randle Season Stats

2024-25

2023-24

Previous Game (vs. MIA 1/27)

2023-24 Stats

2023-24 Rebounding

2023-24 Defensive

2023-24 Shooting

2023-24 Advanced

Julius Randle Game Log

2024-25

2023-24

Julius Randle Player Profile

Career History

Julius Randle Fantasy Projections

Check back soon for fresh projections!

Julius Randle Latest News

Undergoes successful surgery

Shut down for rest of season

Not yet taking contact

Still practicing limited contact

Practicing with light contact

Julius Randle

#30 PF

Unlock the latest New York Knicks news — direct to your inbox.

Status

Previous game (vs. MIA 1/27)

Latest Julius Randle news Subscribe

2023-24 Season Stats

Latest Julius Randle news